Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Oragenics, Inc. (OGEN) had Cash Flow from Investing Activities of $4.00M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-2.53M |
|
-- |
|
-- |
|
$2.59M |
|
$-2.59M |
|
$0.02M |
|
$-2.58M |
|
$-2.58M |
|
$-2.53M |
|
$-2.53M |
|
$-2.53M |
|
$-2.53M |
|
$-2.59M |
|
$-2.59M |
|
4.43M |
|
4.43M |
|
$-0.57 |
|
$-0.57 |
|
| Balance Sheet Financials | |
$5.49M |
|
-- |
|
-- |
|
$5.49M |
|
$1.82M |
|
-- |
|
-- |
|
$1.82M |
|
$3.67M |
|
$3.67M |
|
$3.67M |
|
4.51M |
|
| Cash Flow Statement Financials | |
$-4.39M |
|
|
Cash Flow from Investing Activities |
$4.00M |
$-0.15M |
|
$4.40M |
|
$3.86M |
|
$-0.54M |
|
$0.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-68.89% |
|
-68.89% |
|
-46.04% |
|
-68.89% |
|
$0.81 |
|
$-0.99 |
|
$-0.99 |
|